These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24756044)

  • 1. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height.
    Modesto Mde J; Amer NM; Erichsen O; Hernandez S; dos Santos CD; de Carvalho JÂ; Pereira RM; França SN; De Lacerda L
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):813-20. PubMed ID: 24756044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth hormone deficiency.
    Sartorio A; Agosti F; De Col A; Mazzilli G; Marazzi N; Busti C; Galli R; Lafortuna CL
    Arch Med Res; 2008 Jan; 39(1):78-83. PubMed ID: 18067999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
    Aimaretti G; Corneli G; Rovere S; Croce CG; Ghigo E; Procopio M
    J Endocrinol Invest; 2005; 28(10 Suppl):28-32. PubMed ID: 16550719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
    Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD.
    Baroncelli GI; Bertelloni S; Sodini F; Saggese G
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):175-84. PubMed ID: 14725678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G; Sunnerhagen KS; Svensson J
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of GH treatment on bone mass in children with GH deficiency.
    Baroncelli GI; Saggese G
    J Endocrinol Invest; 2005; 28(10 Suppl):23-7. PubMed ID: 16550718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
    Koranyi J; Svensson J; Götherström G; Sunnerhagen KS; Bengtsson B; Johannsson G
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of growth hormone on bone: bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone.
    Wright NM; Renault J; Hollis B; Bell NH; Key LL
    J Bone Miner Res; 1995 Jan; 10(1):127-31. PubMed ID: 7747619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance exercise alone improves muscle strength in growth hormone deficient males in the transition phase.
    Amer NM; Modesto MJ; Dos Santos CD; Erichsen O; Mascarenhas LPG; Nesi-França S; Marques-Pereira R; De Lacerda L
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):887-894. PubMed ID: 30052519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency.
    Sartorio A; Ortolani S; Conti A; Cherubini R; Galbiati E; Faglia G
    J Endocrinol Invest; 1996 Sep; 19(8):524-9. PubMed ID: 8905475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.
    Johansson AG; Forslund A; Hambraeus L; Blum WF; Ljunghall S
    J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A; Murray RD; Shalet SM
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study.
    van der Sluis IM; Boot AM; Hop WC; De Rijke YB; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2002; 58(5):207-14. PubMed ID: 12401939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid patterns in treated growth hormone deficient children vs. short stature controls.
    Foster C; Burton A; Scholl J; Scott ML; Gunter V; McCormick K
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):909-14. PubMed ID: 24859507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.